6 x Pharmaqo Sustanon 250mg x 10ml

Description

6 x Pharmaqo Sustanon 250mg x 10ml

6 x Pharmaqo Sustanon 250mg x 10ml is a bulk listing for an injectable testosterone product identified as Sustanon 250. The supplied listing contains 6 x 10ml units, providing 60ml in total, with a stated strength of 250mg.

Sustanon 250 is a testosterone preparation containing four testosterone esters. The currently authorised UK reference product contains testosterone propionate, testosterone phenylpropionate, testosterone isocaproate and testosterone decanoate in an oily solution. It is a prescription-only medicine used for testosterone replacement therapy in men with confirmed hypogonadism.

The specific Pharmaqo Sustanon 250mg x 10ml product should not automatically be assumed to be identical to the authorised Aspen Sustanon 250 product. Its manufacturer, formulation, excipients, concentration, authenticity and regulatory status should be independently verified.

Classification

Product type: Injectable testosterone preparation
Common active ingredient: Testosterone esters
Listed strength: 250mg
Pack size: 10ml
Bulk quantity: 6 x 10ml = 60ml
Reference UK medicine: Sustanon 250, 250mg/ml solution for injection
UK regulatory context: Testosterone is a Class C, Schedule 4 Part 2 controlled substance.

The authorised UK Sustanon 250 formulation contains four testosterone esters per ml: 30mg testosterone propionate, 60mg testosterone phenylpropionate, 60mg testosterone isocaproate and 100mg testosterone decanoate. Together these contain 176mg of actual testosterone per ml.

What is 6 x Pharmaqo Sustanon 250mg x 10ml?

6 x Pharmaqo Sustanon 250mg x 10ml is a bulk presentation of an injectable testosterone product labelled as Sustanon 250.

Sustanon-type formulations combine testosterone esters with different durations of activity. After administration, the ester groups are hydrolysed and release testosterone into the circulation. The authorised Sustanon 250 product contains four separate testosterone esters designed to provide different release characteristics.

The authorised UK product is supplied as a clear, pale-yellow oily solution for deep intramuscular injection. Its excipients include refined arachis oil and benzyl alcohol.

These details should not automatically be applied to the Pharmaqo product without verification.

Dosage

There is no independently verified UK-authorised dosing regimen specifically for Pharmaqo Sustanon 250mg x 10ml.

For the authorised UK Sustanon 250 medicine, the SmPC states that dosage should be adjusted according to individual response and testosterone concentrations. For adult men, the usual licensed regimen is 1ml every three weeks, under medical supervision.

This authorised regimen should not be interpreted as a recommended bodybuilding cycle or transferred automatically to the Pharmaqo product.

Testosterone replacement should only be considered following appropriate clinical assessment and biochemical confirmation of testosterone deficiency.

How Does Pharmaqo Sustanon 250mg x 10ml Work?

Testosterone is the principal endogenous androgen and acts through androgen receptors in target tissues.

The testosterone esters in Sustanon are converted into testosterone after entering the circulation. Testosterone then binds to androgen receptors and influences gene transcription and protein production.

Testosterone can also be converted into dihydrotestosterone (DHT) and oestradiol, contributing to different physiological effects.

In men with confirmed testosterone deficiency, authorised Sustanon 250 treatment can restore testosterone concentrations towards the physiological range and improve symptoms associated with hypogonadism.

Potential Benefits

When medically indicated for confirmed hypogonadism, testosterone replacement may help improve symptoms associated with testosterone deficiency.

The authorised Sustanon 250 SmPC reports that testosterone replacement in hypogonadal men can improve testosterone-deficiency symptoms, sexual function and libido, while also increasing lean body mass and bone mineral density.

Potential therapeutic benefits can include:

• Improvement of symptoms associated with testosterone deficiency
• Support for normal sexual function
• Maintenance of bone health
• Support for lean body mass
• Restoration of androgen-dependent physiological functions
• Normalisation of testosterone concentrations where deficiency has been confirmed

These potential benefits relate to medically indicated testosterone replacement and should not be interpreted as guaranteed effects of the specific Pharmaqo product.

When Should You Not Take Pharmaqo Sustanon 250mg x 10ml?

Testosterone treatment is contraindicated in certain circumstances.

The authorised Sustanon 250 product is contraindicated in people with:

• Known or suspected prostate cancer
• Known or suspected male breast cancer
• Pregnancy
• Breastfeeding
• Hypersensitivity to testosterone or its ingredients
• Peanut allergy
• Soya allergy because of the potential relationship with peanut allergy and the presence of refined arachis oil.

Additional medical assessment is important for people with cardiovascular disease, hypertension, prostate symptoms, sleep apnoea, liver or kidney disease, elevated haematocrit or fertility concerns.

Mechanism

Sustanon contains four testosterone esters with different durations of action.

Following administration, the esters are hydrolysed to testosterone. Testosterone enters target cells and binds to androgen receptors, producing changes in gene expression and protein synthesis.

Testosterone can subsequently be converted into DHT through 5-alpha-reductase or oestradiol through aromatase.

The authorised Sustanon 250 SmPC reports increases in testosterone, DHT, oestradiol and androstenedione following treatment, alongside changes in gonadotrophin levels in hypogonadal men.

Uses

The authorised UK Sustanon 250 medicine is indicated for testosterone replacement therapy in adult men with male hypogonadism where testosterone deficiency has been confirmed through clinical features and biochemical testing.

The authorised product information also describes testosterone administration as supportive therapy for female-to-male transgender individuals.

The specific Pharmaqo product should not automatically be described as having these licensed indications unless its own regulatory status has been verified.

It should not be presented as an approved treatment for bodybuilding, athletic performance enhancement or general muscle gain.

Warnings and Precautions

Testosterone treatment requires ongoing medical monitoring.

The authorised Sustanon 250 SmPC recommends monitoring testosterone concentrations at baseline and at regular intervals, with treatment adjusted individually to maintain appropriate testosterone levels.

Important precautions include:

• Testosterone can increase haematocrit and haemoglobin.
• Blood pressure may increase.
• Prostate size and urinary symptoms may be affected.
• Testosterone can suppress natural gonadotrophin signalling and sperm production.
• Fertility may therefore be reduced.
• Fluid and sodium retention can occur.
• Lipid levels can change.
• Cardiovascular, hepatic and psychiatric adverse effects have been associated with testosterone misuse.
• Excessive androgen exposure can lead to serious complications.

The authorised SmPC specifically warns that misuse of testosterone and other anabolic-androgenic steroids can result in serious cardiovascular, hepatic and psychiatric adverse reactions.

Side Effects

Potential adverse effects associated with testosterone treatment include:

• Acne and oily skin
• Increased haematocrit
• Increased blood pressure
• Fluid retention
• Oedema
• Gynaecomastia
• Changes in libido
• Increased or persistent erections
• Reduced sperm production
• Reduced fertility
• Changes in prostate-related symptoms
• Changes in lipid levels
• Mood or behavioural changes
• Injection-site reactions

The authorised Sustanon product also notes the possibility of polycythaemia resulting from increased haemoglobin and haematocrit.

Oily injectable testosterone preparations can rarely cause pulmonary oil microembolism-type reactions. Symptoms such as coughing, breathing difficulty, chest discomfort, dizziness or fainting following an injection require urgent medical attention.

Storage

The authorised UK Sustanon 250 product should be stored below 30°C, not refrigerated or frozen, and kept in the original packaging to protect it from light.

For 6 x Pharmaqo Sustanon 250mg x 10ml, the manufacturer’s own storage instructions should be followed because the exact Pharmaqo formulation has not been independently verified.

Keep the product securely away from children and do not use damaged or visibly abnormal containers.

Where to Buy 6 x Pharmaqo Sustanon 250mg x 10ml?

To get 6 x Pharmaqo Sustanon 250mg x 10ml  online, go to Steroid Sanctuary today to get the best deal on this medicine.

Frequently Asked Questions

1. What is 6 x Pharmaqo Sustanon 250mg x 10ml?

It is a bulk listing containing 6 x 10ml units, providing 60ml in total, with a stated strength of 250mg. The name Sustanon commonly refers to a mixture of testosterone esters.

2. What is in authorised Sustanon 250?

The authorised UK Sustanon 250 contains four testosterone esters per ml: 30mg testosterone propionate, 60mg testosterone phenylpropionate, 60mg testosterone isocaproate and 100mg testosterone decanoate. The combined amount corresponds to 176mg of testosterone per ml.

3. What is Sustanon 250 used for?

The authorised UK product is used for testosterone replacement therapy in adult men with confirmed male hypogonadism. Testosterone deficiency should be demonstrated through appropriate clinical and biochemical assessment.

4. Can Sustanon affect fertility?

Yes. Testosterone treatment can suppress the hormonal signals responsible for normal sperm production and may reduce fertility. This is particularly important for people who are planning to have children.

5. Is Sustanon a controlled substance in the UK?

Testosterone is listed as a Class C, Schedule 4 Part 2 controlled substance under UK controlled-drug legislation.